Myriad Asset Management US’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.77M Buy
+1,480
New +$1.51M 2.45% 8
2022
Q3
Sell
-12,300
Closed -$3.99M 35
2022
Q2
$3.99M Buy
+12,300
New +$3.69M 0.92% 16

Other funds holding LLY

Myriad Asset Management US's LLY Position: Q2 2026 in Review

Myriad Asset Management US opened a new position in Eli Lilly (LLY) in Q2 2026: 1,480 shares worth $1.77M. The stake represents 2.45% of the portfolio and ranks #8 among its holdings. This is a return to the name: Myriad Asset Management US previously reported a position in LLY as recently as Q2 2022.

Myriad Asset Management US first reported a position in LLY in Q2 2022 and has held it in 2 quarters since. The position peaked at $3.99M in Q2 2022. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Myriad Asset Management US held 1,480 shares of Eli Lilly worth $1.77M as of Q2 2026.
  • Eli Lilly was a new Myriad Asset Management US position in Q2 2026.
  • Eli Lilly made up 2.45% of Myriad Asset Management US's portfolio in Q2 2026, its #8 holding.
  • Myriad Asset Management US first reported a position in Eli Lilly in Q2 2022 and has held it in 2 quarters since.
  • Myriad Asset Management US's Eli Lilly position peaked at $3.99M in Q2 2022.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Myriad Asset Management US's 13F filing for Q2 2026, filed 20 Jul 2026.